(This webinar is part of RRP's "Hereditary Hematologic Malignancies: Not That Rare" medical education webinar series)

Dr. Kelly Bolton (Washington University School of Medicine) discusses how inherited (germline) genetic factors influence the development of blood cancers, the growing role of germline testing in patient care, and emerging strategies for early intervention.

The session concludes with a panel discussion featuring Dr. Gina Keiffer (Thomas Jefferson University) and Dr. Abhishek A. Mangaonkar (Mayo Clinic).

Learning Objectives:

• Understand how germline mutations interact with somatic mutations to influence blood cancer risk.

• Recognize the importance of germline genetic testing in patients with hematologic malignancies.

• Identify how germline findings can impact clinical care decisions, including transplant donor selection.

• Describe new research efforts aimed at early detection and intervention in individuals with inherited predispositions.